Healthcare provider profile · identity verified

Christopher John Bero

Internal Medicine · CARLISLE, PA · NPI 1659366235

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	893	240
Lisinopril	Lisinopril	540	149
Omeprazole	Omeprazole	398	116
Levothyroxine Sodium	Levothyroxine Sodium	311	75
Rosuvastatin Calcium	Rosuvastatin Calcium	309	80
Metoprolol Succinate	Metoprolol Succinate	266	67
Simvastatin	Simvastatin	256	64
Losartan Potassium	Losartan Potassium	247	67
Pantoprazole Sodium	Pantoprazole Sodium	247	72
Amlodipine Besylate	Amlodipine Besylate	228	67
Hydrochlorothiazide	Hydrochlorothiazide	211	55
Furosemide	Furosemide	204	56
Metformin Hcl	Metformin Hcl	188	49
Sertraline Hcl	Sertraline Hcl	175	51
Gabapentin	Gabapentin	167	47
Pravastatin Sodium	Pravastatin Sodium	163	43
Eliquis	Apixaban	137	26
Carvedilol	Carvedilol	129	36
Duloxetine Hcl	Duloxetine Hcl	115	31
Ezetimibe	Ezetimibe	113	36
Lorazepam	Lorazepam	111	26
Potassium Chloride	Potassium Chloride	106	32
Montelukast Sodium	Montelukast Sodium	103	28
Clopidogrel	Clopidogrel Bisulfate	101	27
Famotidine	Famotidine	99	29
Metoprolol Tartrate	Metoprolol Tartrate	92	24
Farxiga	Dapagliflozin Propanediol	90	18
Glimepiride	Glimepiride	84	21
Trazodone Hcl	Trazodone Hcl	83	20
Celecoxib	Celecoxib	82	25
Synthroid	Levothyroxine Sodium	82	19
Alendronate Sodium	Alendronate Sodium	80	19
Fluticasone Propionate	Fluticasone Propionate	76	39
Isosorbide Mononitrate Er	Isosorbide Mononitrate	76	15
Tamsulosin Hcl	Tamsulosin Hcl	74	22
Atenolol	Atenolol	71	21
Clonazepam	Clonazepam	70	11
Allopurinol	Allopurinol	69	15
Jardiance	Empagliflozin	68	15
Xarelto	Rivaroxaban	68	14
Fluoxetine Hcl	Fluoxetine Hcl	66	19
Escitalopram Oxalate	Escitalopram Oxalate	63	19
Tramadol Hcl	Tramadol Hcl	59	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	57	20
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	54	14
Alprazolam	Alprazolam	52	15
Metformin Hcl Er	Metformin Hcl	52	15
Albuterol Sulfate Hfa	Albuterol Sulfate	50	30
Citalopram Hbr	Citalopram Hydrobromide	50	15
Prednisone	Prednisone	50	22
Buspirone Hcl	Buspirone Hcl	49	16
Quetiapine Fumarate	Quetiapine Fumarate	45	suppressed
Meloxicam	Meloxicam	42	11
Esomeprazole Magnesium	Esomeprazole Magnesium	39	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	39	12
Fenofibrate	Fenofibrate Nanocrystallized	36	suppressed
Januvia	Sitagliptin Phosphate	33	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	22
Ramipril	Ramipril	29	suppressed
Glipizide Er	Glipizide	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Tradjenta	Linagliptin	26	suppressed
Bumetanide	Bumetanide	25	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Invokana	Canagliflozin	25	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Colchicine	Colchicine	23	11
Risedronate Sodium	Risedronate Sodium	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	19
Lovastatin	Lovastatin	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Pregabalin	Pregabalin	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	11
Triamcinolone Acetonide	Triamcinolone Acetonide	18	14
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Finasteride	Finasteride	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Naproxen	Naproxen	16	suppressed
Nitroglycerin	Nitroglycerin	16	11
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Valsartan	Valsartan	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Baclofen	Baclofen	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Cephalexin	Cephalexin	14	14
Chlorthalidone	Chlorthalidone	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Methylprednisolone	Methylprednisolone	13	13
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Celebrex	Celecoxib	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	12
Enalapril Maleate	Enalapril Maleate	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Lactulose	Lactulose	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error